Fortress Biotech to Participate in Three September 2021 Investor Conferences
NEW YORK, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on acquiring, developing and commercializing or monetizing promising biopharmaceutical products and product candidates cost-effectively, today announced that Lindsay A. Rosenwald, M.D., Chairman, President and Chief Executive Officer, will participate in three virtual investor conferences in September 2021.
Details of the events are as follows:
About Fortress Biotech
Investor Relations Contact:
Media Relations Contact:
Harmonizing the Data from the Factory Floor
Keynote Presentation - Open to all Badge Holders
Is it Time to Leave AI Unsupervised?